您当前的位置：
首页 >
文章列表页 >
Research progress of the role of CD133+ cancer stem cells in colorectal cancer progression and targeted immunotherapy
Medical Journal of Chinese People′s Liberation Army   Vol. 51, Issue 6, Pages: 947-956(2026)
Review | 更新时间：2026-07-15

    • Research progress of the role of CD133+ cancer stem cells in colorectal cancer progression and targeted immunotherapy

    • DOI：10.11855/j.issn.0577-7402.0140.2025.0922    

      CLC： R73

    • Received：21 January 2025，

      Accepted：29 March 2025，

      Published：28 June 2026

    移动端阅览

  • Li Rui-Yang,Luo Sen,Ye Ting.Research progress of the role of CD133+ cancer stem cells in colorectal cancer progression and targeted immunotherapy[J].Medical Journal of Chinese People′s Liberation Army,2026,51(06):947-956. DOI: 10.11855/j.issn.0577-7402.0140.2025.0922. DOI：

  •  
  •  

0

Views

275

下载量

0

CSCD

0

CNKI被引量

>
Alert me when the article has been cited
提交
Outline
No Sections

Related Articles

Effects of M2-type macrophage-derived XBP1 on oxaliplatin resistance in colorectal cancer cells by regulating SREBP2
Application value of preoperative hemoglobin/red cell distribution width ratio, prognostic nutritional index, and carcinoembryonic antigen in the diagnosis of colorectal cancer
Research progress on cholesterol metabolism in the regulation of colorectal cancer
Value of tumor growth pattern and tumor budding on judgment of patient’s prognosis with stageⅠ-Ⅲ colorectal cancer
Current research status of miR-126 in human malignant tumors

Related Author

Li Rui-Yang
Luo Sen
Ye Ting
Zhao Bin
Liu Ji-Pan
Zhang Li
Liu Ya-Bin
Chen Yu-Ting

Related Institution

Department of Laboratory Medicine, the Affiliated Hospital of Southwest Medical University
School of Clinical Medical Sciences, Southwest Medical University
Department of General Surgery, the Fourth Hospital of Hebei Medical University
Department of Chemistry, Hengshui University, , Heibei
Department of Anorectal and Pediatric Surgery, Hengshui People's Hospital
0